Riskpilot← Back to searchSign inGet full accessBioImpakt i Örebro AB
ABActiveOrg 5590045018Drevevägen 18 CResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20151 employees
Revenue 2025
SEK 583K
+321% vs 2024
EBITDA margin
3.1%
+255% vs 2024
Equity ratio
95.4%
Financial strength
Net profit 2025
SEK 5K
+119% vs 2024
| Revenue | SEK 583K | +321% |
| EBITDA | SEK 18K | +255% |
| Net profit | SEK 5K | +119% |
| Total assets | SEK 227K | +0% |
| Equity | SEK 217K | +2% |
| Employees | 1 | — |
Legal name
BioImpakt i Örebro AB
Org number
5590045018
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19 februari 2015
Share capital
SEK 250 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av ledamöterna Firman tecknas ensam av Olsson, Per Erik
Company purpose
Föremålet för bolagets verksamhet är att utföra biologiska och kemiska analyser, bedriva forskning och utveckling, konsultverksamhet, rådgivning samt utbildning inom bioteknik, hälso- och miljöriskbedömningar. Företaget kommer också att bedriva försäljning av miljörelaterade mätsystem och risk- bedömningsunderlag och därmed förenlig verksamhet.
Address
Drevevägen 18 C
Email
per-erik.olsson@bioimpakt.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 425 | 306 | 104 | 138 | 583 |
| Staff expenses | — | −237 | −86 | −2 | −197 |
| EBITDA | 7 | −50 | −94 | −12 | 18 |
| Depreciation & amort. | −0 | −5 | −14 | −14 | −14 |
| EBIT | 7 | −55 | −108 | −25 | 5 |
| Net financials | — | 0 | 0 | −0 | 0 |
| Profit before tax | 7 | −55 | −107 | −26 | 5 |
| Tax | −0 | — | — | — | — |
| Net profit | 7 | −55 | −107 | −26 | 5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 479 | 426 | 277 | 228 | 227 |
| Equity | 400 | 345 | 238 | 212 | 217 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 79 | 81 | 39 | 16 | 10 |
| Total debt | 79 | 81 | 39 | 16 | 10 |
EBITDA margin
3.1%
This company
15.8%
Market median
-80% vs market
20212025
Equity ratio
95.4%
This company
38.2%
Market median
+150% vs market
20212025
Return on equity
2.2%
This company
18.4%
Market median
-88% vs market
20212025
Net profit margin
0.8%
This company
8.1%
Market median
-90% vs market
20212025
Asset turnover
2.56×
This company
1.12×
Market median
+129% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PE Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2024 | |
| Former (5) | ||
| Board of Directors | 2022 – 2026 | |
| Deputy Board Member | 2022 – 2024 | |
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2026 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 59% | 59% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OruPharma i Örebro AB
BioImpakt i Örebro AB Board members of BioImpakt i Örebro AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Erik Olsson | Chief Executive Officer | 0 companies |
| Mats Oscar Torring | Board of Directors | 0 companies |
| Kjell Christer Forsgren | Deputy Board Member | 0 companies |
| Anna Sofi Ragén | Board of Directors | 0 companies |
| Nils Martin Daniel Ragnvaldsson | Chairman | 0 companies |
| Jana Jass | Deputy Board Member | 0 companies |
| Björn Erik Johnny Karlsson | Board of Directors | 0 companies |
| Torbjörn Bertil Ros | Board of Directors | 0 companies |